Skip to NavigationSkip to content

Business Services

Top Ten most popular articles on this week

Corruption and bribery feature heavily in the news this week. A recently exposed 1997 email chain shows Dr Richard Sackler, member of the billionaire founding family of Purdue Pharma, knew about the potential abuse of opioids by its clients. In India, a recent report by the Support for Advocacy and Training to Health Initiatives (Sathi) revealed the widespread use of bribes by pharmaceutical companies in India, and how they take advantage of the lax government penalties against such actions.

Partnership with payers: Communicating and negotiating with impact

NDA's Lisa Peluso, Director, Coaching and Client Engagement, outlines key strategies for interacting with audiences and payers while maximising team alignment when it comes to delivering a product to market.

Dr Richard Torbett is named as the new Chief Executive of the ABPI

Published on: 05/12/19

The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr Richard Torbett as its new Chief Executive. He will assume the position on 1 January 2020.

The appointment comes after his predecessor, Mike Thompson, stepped down in June. He had served in the role since March 2016. Torbett was unanimously selected by the ABPI board after an external recruitment process with an executive search agency.

Patient experience: Living with desmoid fibromatosis

Published on 04/12/19 at 12:51pm

Lisa Pascoe lives with a rare, benign desmoid tumour in her abdomen. She opens up to Pharmafocus on her diagnosis and experience with the UK healthcare system, as well as her advocacy for Desmoid United UK and her proactive approach to change things for the better.

Can you explain a bit about your condition?

Exclusive interview: Samsung Bioepis' Sang-Jin Pak on the rise of biosimilars

Published on 02/12/19 at 12:22pm

Following on from our focus on biosimilars in our feature last week, you can read Nikhil Patel's interview with Sang-Jin Pak, Senior Vice President & Head of Commercial at Samsung Bioepis, where he discusses the increasing prevalence of biosimilar medications and where the company stands within this.

How do you think policymakers can make biosimilars more viable options in the US market to achieve greater uptake?

Top Ten most popular articles on this week

The NHS was featured heavily in the news this week. Jeremy Corbyn revealed documents detailing previous UK-US discussions in which opening up the NHS to US drug firms were brought up. A report was also released this week showing that the majority of British people are concerned about the fate of the NHS due to the US trade deal; however this survey was conducted before this week’s revelations.

The coming age of biosimilars

Published on 25/11/19 at 03:58pm

With more and more biosimilars securing approval and the sheer potential value they have to offer for healthcare systems around the world, Nikhil Patel takes a look at the current market landscape and how things could be shifting for the better.

Bringing the clinical trial home

Published on 18/11/19 at 01:07pm

Clinical trials are the backbone of healthcare and drug research, but many key patient populations have in the past been unable to take part in these trials because of their traditional format. Fortunately, technology has risen to the challenges of modern research and provided a solution, as Matt Fellows discovers.

Top Ten most popular articles on this week

As we close in on the weekend, it's been a week characterised by data reveals and crucial marketing approvals, including the big news that the deal struck between NHS England and Vertex to provide access to its cystic fibrosis portfolio for English patients has now been adopted in Northern Ireland and Wales.

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, who in her new role will galvanise research and patient advocacy efforts within the company in the spirit of “advancing the organisation’s impact within the blood cancer research community”.

McDonald joins the organisation from fellow non-profit Sarcoma UK where she served as Director of Research and Policy. In the role, she led the organisation’s research programme and was a key player in securing £870,000 worth of funding for its clinical, lab-based and genomic research projects.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches